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ABSTRACT
The yeast Snu13p protein and its 15.5K human
homolog both bind U4 snRNA and box C/D
snoRNAs. They also bind the Rsa1p/NUFIP
assembly factor, proposed to scaffold immature
snoRNPs and to recruit the Hsp90-R2TP chaperone
complex. However, the nature of the Snu13p/
15.5K–Rsa1p/NUFIP interaction and its exact role
in snoRNP assembly remained to be elucidated.
By using biophysical, molecular and imaging
approaches, here, we identify residues needed for
Snu13p/15.5K–Rsa1p/NUFIP interaction. By NMR
structure determination and docking approaches,
we built a 3D model of the Snup13p–Rsa1p inter-
face, suggesting that residues R249, R246 and K250
in Rsa1p and E72 and D73 in Snu13p form a
network of electrostatic interactions shielded from
the solvent by hydrophobic residues from both
proteins and that residue W253 of Rsa1p is inserted
in a hydrophobic cavity of Snu13p. Individual muta-
tions of residues in yeast demonstrate the func-
tional importance of the predicted interactions for
both cell growth and snoRNP formation. Using
archaeal box C/D sRNP 3D structures as templates,
the association of Snu13p with Rsa1p is predicted to
be exclusive of interactions in active snoRNPs.
Rsa1p and NUFIP may thus prevent premature
activity of pre-snoRNPs, and their removal may be
a key step for active snoRNP production.
INTRODUCTION
During the last decades, numerous ribonucleoprotein par-
ticles (RNPs) containing small non-coding RNAs and
proteins have been discovered in eukaryotes. Several of
them share the common property to contain a primary
RNA-binding protein which belongs to the L7Ae family
of protein (‘L7Ae-like’ proteins) (1–3). They will be
denoted here L7Ae RNPs. Members of this L7Ae RNP
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family play several essential roles in eukaryotic cells: (i)
small nucleolar RNPs (box C/D and box H/ACA
snoRNPs) are required for generation of mature riboso-
mal RNAs starting from pre-ribosomal RNA transcripts
(maturation and post-transcriptional modiﬁcations) (4,5);
(ii) the spliceosomal U4 small nuclear RNP (U4 snRNA)
is an essential component of the pre-mRNA splicing
machinery (6); (iii) small Cajal body-speciﬁc RNPs (box
C/D and H/ACA scaRNPs) catalyse the post-transcrip-
tional modiﬁcations of spliceosomal UsnRNPs (7); (iv)
the vertebrate telomerase holoenzyme is needed for
telomere synthesis (8,9); and (v) speciﬁc RNA–protein
complexes which are assembled on the 30 UTR regions
of selenoprotein mRNAs (SECIS mRNPs) are required
for selenocysteine incorporation (1,10). In their active
forms, these various L7Ae RNPs consist of an RNA
molecule containing a recognition motif for the ‘L7Ae-
like’ protein and a set of speciﬁc proteins. The L7Ae
RNPs can be divided into different classes depending on
the identity of the ‘L7Ae-like’ protein they contain: verte-
brate’s protein 15.5K (Snu13p in yeast) is a component of
the U4 snRNP, box C/D snoRNPs and box C/D scaRNPs
(3,11,12); vertebrate’s protein NHP2 (Nhp2p in yeast) is
found in H/ACA snoRNPs, H/ACA scaRNPs and the
telomerase RNP (13,14); ﬁnally, vertebrate’s protein
SBP2 is speciﬁc for selenocysteine mRNPs (1,10).
The 3D structures established for human 15.5K and
yeast Snu13p proteins are very similar (15,16), showing a
high conservation throughout evolution. These two
proteins recognize very similar K-turn motifs
characterized by the presence of two helices, I and II,
separated by a 3-nt long bulge-loop (3,16). One main
feature of the K-turn 3D structure is the sharp angle
formed by the backbone of the bulge-loop (16,17). It is
generated by stacking of residues at positions 1 and 2 in
the bulge on helices I and II, respectively. As a conse-
quence, the U residue at position 3 in the loop, which is
highly conserved in K-turn motifs and recognized by
proteins of the L7Ae family, is protruding outside of the
motif and plays a key role in the RNA–protein interaction
(16). The two non-canonical sheared G:A base pairs at the
extremity of helix II are also involved in this interaction
(3,16,18,19). Binding of 15.5K/Snu13p allows further
recruitment of the other speciﬁc core proteins: PRP31
for U4 snRNP (20), U3-55K (Rrp9p in yeast) on the U3
B/C motif (18,21), and NOP56, NOP58 and Fibrillarin
(Nop1p in yeast) on box C/D snoRNAs as well as box
C/D scaRNAs (22,23). The variable elements in K-turn
motifs, i.e. length of helix I and sequence of helix II are
key determinants for the selective recognition of these
speciﬁc proteins (18,23,24). The determination of the
crystal structure of the human PRP31 fragment encom-
passing amino acids 78–333 (PRP3178–333) in complex with
15.5K and a fragment of U4 snRNA (25), as well as the
crystal structure of archaeal box C/D RNPs (26–28) have
provided some clues to understand how diversity is
generated on a common theme: namely, how very
similar architecture formed by a K-turn motif bound to
an ‘L7Ae-like’ protein can interact speciﬁcally with differ-
ent sets of proteins. Although, it is well admitted that the
15.5K/Snu13p primary binding proteins play a key role in
initiation of the L7Ae RNP biogenesis, one key remaining
question is to know how these RNP complexes are
assembled in vivo with a high degree of speciﬁcity.
Indeed, whereas, assembly of the archaeal counterparts
of snoRNPs seems to be mainly based on the capacity
of their components to interact together (29–32), recent
studies revealed an unexpected complexity of the
snoRNP biogenesis pathways in eukaryotes (2,33–39).
Eukaryotic RNAs are most generally produced in a pre-
cursor form that is subsequently processed and assembled
with proteins. Up to now, only the biogenesis of verte-
brate’s spliceosomal UsnRNPs is completely deciphered
(37). Progresses were also made in the identiﬁcation of
cellular factors which are speciﬁcally required for H/
ACA snoRNP biogenesis and determination of their
roles. These factors interact with the nascent precursors
of H/ACA RNAs (40,41). Some of them, like NAF1/
Naf1p, function by mimicking and replacing a core
protein in the immature particle, rather than as an
external scaffold as in the case of the snRNA and the
SMN complex (42). The Shq1p assembly factor mimics
the RNA-binding surface, to prevent association of the
H/ACA proteins with non-speciﬁc RNAs (43,44).
As mentioned above, one fascinating remaining
question is to understand how by recognition of very
similar K-turn motifs and with the assistance of RNP
assembly factors, Snu13p/15.5k speciﬁcally initiates the
assembly of three different kinds of RNPs (box C/D
snoRNPs, the U4 snRNP and the B/C protein complex
of the U3 snoRNP) (3,18,20–23). We recently found that
the vertebrate’s NUFIP protein and the yeast Rsa1p
protein (45) play a key role in this process and more gen-
erally in assembly of RNPs of the L7Ae family (2,36,46).
These platform proteins facilitate formation of a macro-
complex containing both the core RNP proteins and the
assembly factors. More precisely, NUFIP/Rsa1p is
proposed (i) to hold together core proteins in the
immature particles; and (ii) to recruit the Hsp90-R2TP
chaperone complex (2,39). The yeast and human core
R2TP complexes are composed of four proteins: Pih1p
(PIH1D1/NOP17 in human), Tah1p (hSpagh also named
RPAP3 in human), Rvb1p (TIP49, also known as Pontin
or p55 in vertebrates), Rvb2 (TIP48 also known as Reptin
or p50 in vertebrates) (2,47). Protein PIH1D1/Pih1p inter-
acts with protein RPAP3/Tah1p within the R2TP complex
(2,47,48). By its interaction with NUFIP/Rsa1p, it is
proposed that PIH1D1 allows the tethering of the R2TP
complex on the pre-RNP (2), whereas by its interaction
with Hsp90 (Hsp82 in yeast), protein RPAP3/Tah1p
allows the recruitment of the chaperone on the pre-
RNP. The two other proteins of the R2TP complex,
TIP48 and TIP49 are AAA+ ATPases. They interact
together and with the PIH1D1(Pih1p)-RPAP3(Tah1p)
heterodimer (2,39,47). The implication of Hsp90 in the
biogenesis of L7Ae RNPs was shown by the disappear-
ance of newly synthesized U4, box C/D and telomerase
RNAs, as well as of 15.5K, NOP58 and NHP2 proteins,
upon inhibition of Hsp90 activity, suggesting that these
proteins are clients of the chaperone (2,39). Therefore,
as compared to UsnRNP assembly, snoRNP assembly
provides a very different paradigm for RNP assembly
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and is an excellent model to decipher mechanisms
ensuring speciﬁcity of RNP assembly.
Although, association of NUFIP/Rsa1p to the ‘L7Ae-
like’ proteins appears to be important for RNP assembly,
NUFIP and Rsa1p show a poor degree of similarity. We
previously identiﬁed a sequence of 37 amino acids that is
highly conserved in the two proteins (hPEP in NUFIP and
yPEP in Rsa1p), and showed that these sequences are
essential for association of NUFIP and Rsa1p with
proteins 15.5K and Snu13p, respectively (2). Here, we
used yeast molecular genetics, biochemical assays, cell
imaging, NMR spectroscopy and molecular modeling ex-
periments to: (i) identify the interacting amino acids in the
NUFIP-–15.5K and Rsa1p–Snu13p complexes; (ii) estab-
lish the solution 3D structure of a fragment of the PEP
region containing the interacting amino acids and a 3D
structure model of its interaction with Snu13p; (iii) deter-
mine the respective functional importance of the Rsa1p
and Snu13p interacting amino acids. In vivo substitution
of Snu13p and Rsa1p interacting amino acids in yeast
demonstrated their requirement for cell growth and the
stability of box C/D snoRNAs. The structural model
that we provide can explain why NUFIP/Rsa1p maintains
immature snoRNP particles in an inactive conformation.
It suggests that removal of NUFIP/Rsa1p is a key event
during snoRNP maturation.
MATERIALS AND METHODS
Recombinant plasmids used in this study
Plasmids were manipulated by standard techniques.
Mutations were generated using the QuickChange muta-
genesis system according to the manufacturer’s instruc-
tions (Stratagene) and appropriate primer pairs.
The bacterial expression vector pGEX-6P-1::SNU13
was already described (19). To express the C-terminal
152 amino acids fragment of Rsa1p in Escherichia coli, a
BglII-XhoI restriction fragment was released by digestion
of plasmid pACTII::Rsa1p230–381 (previously designated
as pACTII::N3C1) (2), and cloned into plasmid
pET30c (Novagen). A 111 bp fragment containing the
Rsa1p coding sequence of amino acids 230–266 was ob-
tained by PCR ampliﬁcation using two primers that
generated a NheI site at one end and an XhoI site at the
other end. To obtain the E. coli expression vector
pET28a::RSA1230–266, this fragment was inserted
between the NheI and XhoI sites of plasmid pET28a
(Novagen).
For protein co-expression in E. coli, DNA fragments
encoding the full-length Rsa1p, the Rsa1p230–381
fragment or protein Pih1p were ampliﬁed by standard
PCR procedures, using primers that generated NdeI and
BamHI restriction sites, and they were inserted in the
pnCS vector (49–51). On the other hand, the Snu13p
and Tah1p ORFs were inserted in the pnEA-3CH vector
in order to produce His-tagged proteins.
For expression of WT or mutated Snu13p or Rsa1p
protein in yeast, the Saccharomyces cerevisiae SNU13
and RSA1 ORFs were PCR ampliﬁed using primers that
generated a BamH1 site at the ORF 50 end and an XhoI
site at its 30 end, and were cloned between the BamH1 and
SalI sites of a centromeric version of the pG1 (TRP1)
expression vector (52). The resulting plasmids were
designated as pG1::SNU13 and pG1::RSA1.
The recombinant plasmids used for Y2H assays were
already described (2). Brieﬂy, the ORFs were cloned by
the Gateway system (invitrogen), or the hybridized com-
plementary oligonucleotides encoding the PEP region and
its variants were cloned in plasmid pACTII downstream
from the GAL4 transactivation domain coding sequence,
or in plasmid pAS2 downstream from the GAL4 DNA-
binding domain coding sequence.
The plasmids coding for mRFP–LacI–NUFIP and
GFP–15.5K were generated with the Gateway technology
with destination vectors previously described (53).
Production of recombinant proteins
The recombinant pGEX-6P-1::SNU13 plasmid was used
to produce WT and mutated GST–Snu13p proteins (19) in
the E. coli BL21-CodonPlus strain (Novagen). GST–
Snu13p proteins were puriﬁed from cell extract under
native conditions, using Glutathione Sepharose 4B as rec-
ommended by the manufacturer (GE Healthcare). They
were cleaved overnight on the beads using the
PreScission protease (GE Healthcare). Compared to
native Snu13p, the cleaved proteins had two additional
G and P residues at their N-terminus. Plasmids
pET30c::RSA1230–381 and pET28a::RSA1230–266 were
used to produce the Rsa1p230–381 and Rsa1p230–266 frag-
ments with an His6 N-terminal tag, in the E. coli BL21-
CodonPlus strain (Novagen). Note that the peptide
produced by plasmid pET28a::RSA1230–266 contained a
15 amino acid sequence resulting from cloning into plas-
mid pET28a which is located between the His6 tag and the
Rsa1p PEP N-terminus. The recombinant His6Rsa1p230–266
and the His6Rsa1p230–381 protein were, respectively,
puriﬁed under native and denaturing/refolding conditions,
using a 5ml His-Trap HP column (GE Healthcare).
Proteins were eluted with 0.5M imidazole at pH 8.
When necessary, the His6 tag was removed by cleavage
with the thrombin protease. After cleavage, or imidazole
elution, proteins were dialysed against buffer D (20mM
HEPES-KOH, pH 7.9; 150mM KCl; 1.5mM MgCl2;
0.2mM EDTA; 10% glycerol) and stored at –80C.
Test of protein–protein interactions by their co-expression
in E. coli
Co-expression tests in E. coli were carried out using the
standard procedure previously described (49). The
pRARE2 E. coli host cells (Novagen) were co-transformed
with plasmids pnEA-3CH and pnCS expressing,
His6Snu13p and full-length Rsa1p or its Rsa1p230–381
fragment, respectively. Growth was performed in 500ml
of 2X concentrated LB medium at 37C to an absorbance
at 600 nm of 0.8. Then, the temperature was switched to
20C and protein co-expression was induced by addition
of isopropyl-b-D-thiogalactopyranoside (Euromedex) at a
1mM ﬁnal concentration. Cells were further grown over-
night at 20C, collected, resuspended in buffer A (20mM
HEPES-NaOH, pH 7.5; 400mM NaCl; 5mM
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b-mercaptoethanol), and lysed by sonication. The soluble
fraction was mixed with 100ml of Talon resin (Clontech),
incubated for 1 h at 4C , the supernatant was removed
and the resin washed extensively with buffer A. Proteins
were eluted from the resin using buffer A containing
500mM imidazole. Eluted proteins were analysed by
SDS-PAGE.
Electrophoresis mobility shift assays
Yeast U14 box C/D snoRNA was synthesized by in vitro
transcription with T7 RNA polymerase using a PCR
fragment carrying the S. cerevisiae snoRNA coding
sequence and was 50 end labeled in conditions previously
described (19). Brieﬂy, after transcription, the RNA was
dephosphorylated by treatment with the CIP enzyme,
and 50 end labeled with T4 polynucleotide kinase in
the presence of [g-32P]ATP, and puriﬁed by gel
electrophoresis. For electrophoresis mobility shift assays
(EMSA), WT or variant Snu13p were mixed with
His6Rsa1p230–266 or His6Rsa1p230–381 fragments each at a
0.5mM ﬁnal concentration in buffer D, and incubated
for 20min at 4C with 5 fmol of 32P-radiolabeled U14
RNA. The RNA–protein complexes formed were
resolved by native gel electrophoresis in conditions
described previously (30).
CD spectroscopy
Circular dichroı¨sm (CD) spectroscopy analyses were
carried out using a Jobin-Yvon Mark VI circular
dichrograph. Quartz spare split-compartment cuvettes
with 0.44 cm path-length per compartment were used for
binding measurements. The relevant protein solution was
placed in one compartment of the cuvette and the target
protein solution in the other compartment. CD spectra
were recorded before and after mixing the cuvette
contents and blanks were run for each interaction and
subtracted from the raw data. At least two spectra were
collected before and after mixing, an average spectrum
was established in order to increase the signal-to-noise
ratio. Spectra were recorded from 202 to 260 nm to test
protein–protein interaction with a scan speed of
0.2 nm s1. Proteins were adjusted at a 4 mM ﬁnal concen-
tration in 10mM Tris-HCl buffer, pH 7.8; 150mM NaCl.
The results are presented as normalized e values. For
protein–protein interactions we used amino acid mean
residue mass of 110Da. Taking into account the residue
concentration and the optical path-length of the cuvette,
the precision of measurements was of d(e)=+/–
0.03 dm3.mol1.cm1.
NMR Spectroscopy and structure calculation
For solubility reasons, a synthetic peptide (GeneCust) of
Rsa1p (Rsa1p238–259) was used for NMR analyses. The
NMR sample of Rsa1p238–259 contained 2mM of peptide
in 10mM NaPi, pH 3.7; 95% H2O; 5% D2O, 150mM
NaCl. NMR data were acquired at 293 and 305 K on a
Bruker Avance III spectrometer equipped with a Z-axis
gradients TCI cryoprobe. For proton resonance assign-
ment, TOCSY spectra using two mixing times (30 and
60ms) and NOESY spectra using three mixing times (75,
150 and 300ms) were recorded. Assignment of
heteronuclei was achieved using 1H–15N HSQC, 1H–13C
HSQC and 1H–13C HSQC-TOCSY (with a mixing time of
60ms) experiments in natural abundance. All spectra were
processed with Topspin 3.0 (Bruker BioSpin) and
analysed with CARA (54). Chemical shifts were deposited
in the Biological Magnetic Resonance Data Bank under
the reference 18959.
For peptide structure calculation, torsion angle
restraints for the , f and 1 angles were derived from
PREDITOR analysis (55) and distance restraints were
derived from NOESY spectra using the automated pro-
cedure of CYANA 2.1 (56). Then, distance and angle
restraints were used for water-reﬁnement of 200 structures
calculated with CNS 1.21 (57). Finally, the 10 structures
with the lowest energies were selected as the most repre-
sentative structures of Rsa1p238–259.
Docking and molecular modeling
Our strategy was to dock the 10 NMR structures of
Rsa1p238–259 with the lowest energies onto the Snu13p
X-ray 3D structure (PDB code 2ALE) using the
Haddock 2.1/CNS 1.21 protocol (58–60). To this end,
we ﬁrst identiﬁed the Snu13p active residues (according
to the Haddock nomenclature) (Table 3) by (i) high pre-
diction scores from both WHISCY and PROMATE
programs (61,62); (ii) high solvent accessibility; (iii)
spatial proximity; and (iv) taking into account residues
found to play key roles in the interaction by experimental
assays. Snu13p passive residues were solvent accessible
residues whose side-chains point toward one or more
active residues (Table 3). For Rsa1p238–259, residues on
the same side of the helix than the experimentally
identiﬁed key residues were considered as ‘active residues’
in Haddock (Table 3). The automated mode of Haddock
2.1 was used to deﬁne semi-ﬂexible segments of Snu13p,
whereas, due to its small size, the entire Rsa1p238–259
fragment was considered as semi-ﬂexible. 4000 structures
were calculated during the rigid body energy minimization
step (it0) and the top 200 best structures were used for the
semi-ﬂexible simulated annealing (it1), and the subsequent
ﬂexible explicit H2O reﬁnement steps (it1-water). The top
10 structures with the best haddock score were selected as
possible models of the interaction.
Then, the structure with the best haddock score was
placed in a water box containing 6074 water molecules
and 3 chlorine ions for ensuring the electrostatic neutrality
of the system. All Arg, Lys, Asp and Glu side-chains were
considered ionic. The resulting system, consisting in a
total number of 20 587 atoms, was energy reﬁned. The
MD program NAMD (63) was employed in combination
with the CHARMM27 force ﬁeld (64) in order to describe
the whole molecular system. Coulomb forces were
evaluated with the particle-mesh Ewald method.
Chemical bonds between hydrogen and heavy atoms
were constrained to their equilibrium value by means of
the SHAKE algorithm. The reﬁnement procedure was
based on several energy minimization steps carried out
by the conjugate gradient method: ﬁrst, the backbone of
the protein complex was ﬁxed such that only the protein
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side-chains and water molecule movements were variable;
next, the whole system was relaxed. Finally, a 5-ns MD
simulation was carried out in the isobaric-isothermal
ensemble, maintaining the pressure and the temperature
at 1.0 atm and 300.0K, respectively, by means of Langevin
dynamics and the Langevin piston approach. The equa-
tions of motion were integrated with a 2-fs time step, using
the r-RESPA algorithm to update short- and long-range
contributions at different frequencies.
Y2H assays
For yeast two-hybrid assays (Y2H), appropriate recom-
binant pACTII and pAS2 plasmids were used to trans-
form haploid cells (strain CG929 or Y190, and strain
Y187, respectively), which were then crossed. Diploids
were selected on media suitable for double selection
(Leu, Trp) and then plated on media suitable
for triple selection (Leu, Trp, His). 3-Amino-
1,2,4-triazol (3AT) was used to evaluate the strength of
the interactions. Growth was assessed after 3 and 5 days of
incubation at 30C.
Tests of the functionality of variant Snu13p and Rsa1p
proteins in yeast
Standard S. cerevisiae growth and handling techniques
were employed. The S. cerevisiae strain YPH499-
GAL::SNU13 (Mata; trp1-63; his3-200; ura3–52;
lys2–801; ade2–101; leu2-1; HIS3::GAL1::SNU13) (3)
was used to test whether Snu13p variants can complement
depletion of the endogenous Snu13p protein. To this end,
strain YPH499-GAL::SNU13 was transformed with re-
combinant pG1::SNU13 plasmids encoding WT or
mutated Snu13p. Cells were grown overnight at 30C in
the Trp selective medium containing galactose as the
carbon source. They were collected by centrifugation,
washed and diluted in Trp selective medium containing
glucose as the carbon source. Cells were grown at 30C
and constantly maintained in exponential phase by
dilution with pre-warmed Trp/Glc medium. The
doubling time was monitored by measuring the absorb-
ance at 600 nm (OD600).
The S. cerevisiae Y190-RSA1 (YPL193W::kanMX2)
strain was obtained by homologous recombination. A
DNA fragment carrying the kanamycin cassette ﬂanked
by sequences ampliﬁed from the RSA1 gene was used to
transform the haploid Y190 strain. Insertion of the kana-
mycin cassette at the RSA1 locus was then veriﬁed by
PCR ampliﬁcations. The RSA1 knock-out strain
obtained displayed a slow growth phenotype as already
observed (45). For functional assays, it was transformed
with plasmid pG1::RSA1 encoding WT or variant Rsa1p,
and grown in YPD medium.
Evaluation of snoRNA levels in yeast
Total RNAs were extracted from exponentially growing
yeast cultures. Northern blot analyses were performed in
standard conditions using 5 mg of total RNAs and speciﬁc
50 end 32P radiolabeled antisense probes:
OG-U1 (50-GACCAAGGAGTTTGCATCAATGA-30);
OG-snR63 (50-TTATGTTGGCCACTCATCAC-30);
OG-snR190 (50-CGAGGAAAGAAGAGACACCATTA
TC-30);
OG-snR45 (50-CCTCAGATCGCTCCGAGA-30);
OG-U14 (50-TCACTCAGACATCCTAG-30);
OG-snR13 (50-AGCTTGAGTTTTTCCACACC-30);
OG-U18 (50-TGTGATAGTCAACCACATCTC-30).
His-pull down assays of in vitro assembled RNPs
100 fmol of 50 end 32P radiolabeled U14 RNA prepared
according to (19) were incubated in the presence of yeast
tRNAs (2 mM) with various sets of recombinant proteins
during 30min in buffer D at 30C: 1 mM of protein
Snu13p and of the His6Tah1p–Pih1p complex were used,
whereas the Rsa1p230–381 fragment was used at a 0.25, 0.5,
1 or 2 mM concentration. The RNP complexes formed
were incubated with Nickel Sepharose beads (GE
Healthcare) for 15min at room temperature in 200 ml of
binding buffer (10mM Tris-HCl, pH 8.0; 150mM NaCl;
0.1% IGEPAL). The beads were washed three times for
10min with 1ml of binding buffer. RNAs were extracted
by phenol-chloroform treatments, ethanol precipitated
and fractionated on a 7% denaturing polyacrylamide gel.
Subcellular localization assay of WT and mutated 15.5K
proteins in HeLa cells
The co-recruitment assay was done as previously
described (53).
RESULTS
Alignment of the NUFIP and Rsa1p amino acid
sequences revealed a low level of sequence similarity,
except for their 37 amino acid long PEP regions
(Figure 1A). Our previous data (2) had emphasized a
major role of these PEP regions for interaction of the
NUFIP and Rsa1p platform proteins, with their respective
15.5K and Snu13p partners. Thus, we used various bio-
chemical, biophysical and genetic methods to identify the
15.5K and Snu13p amino acids which interact with hPEP
and yPEP, respectively, and also to determine which
amino acids of the hPEP and yPEP regions are crucial
for these interactions. Based on the high sequence similar-
ity of the 15.5K and Snu13p proteins (Figure 1B), and of
the hPEP and yPEP regions, we postulated similar modes
of interaction of these two proteins with their PEP partner
regions. Therefore, information on these interactions was
gained by performing some of the experiments on yeast
and other ones in human cells. As in this study we used
several Rsa1p sub-fragments (Figure 1A), each of them
are identiﬁed as Rsa1px–y, where x and y represent the
positions in the Rsa1p amino acid sequence of the
amino acids at the sub-fragment extremities. For hom-
ogenization of the nomenclature, the fragments previously
denoted yeast and human PEP regions will be denoted
here Rsa1p230–266 and NUFIP223–260, respectively.
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Figure 1. Residues in 15.5K helix a3 are involved in the 15.5K–NUFIP223–260 interaction. (A) Schematic representation of the human protein
NUFIP and the yeast protein Rsa1p. The homologous region between the two proteins (named hPEP in human and yPEP in yeast) is colored
in gray. The various fragments of NUFIP and Rsa1p used in this study are represented. (B) The RNA-binding domain shared by members of the
L7Ae family. Multiple amino acid sequence alignments were constructed using CLUSTALW. Secondary structure elements of human protein 15.5K
are labeled on top of the sequences. Numbering corresponds to residues of 15.5K. Identical residues are highlighted in dark gray and similar residues
are in light gray. (C) Yeast two-hybrid interactions between 15.5K and NUFIP, NUFIP223–260 or Alix as a negative control. Tests were also
performed with NHP2, a core protein of box H/ACA snoRNPs. The following residues of 15.5K were changed into alanines, except when indicated.
MutA: H17L18T19K20K21; MutB: K33Q34L35R36; MutC: E61P62E64; MutD: E74D75K76; MutE: R84S85K86; MutF: K107E108K113A114; MutG: Q27Q28;
MutH: N31Y32K33; MutI: E124S R125S; MutJ: N40T43N47.
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15.5K–NUFIP association depends upon the 15.5K
helix a3
To identify the NUFIP interacting domain of 15.5K, the
surface residues in 15.5K were mutagenized into alanines.
A series of ten 15.5K mutants was generated, and the
resulting proteins were tested for association with
NUFIP and the NUFIP223–260 segment (hPEP), by the
use of Y2H assays. Mutations in 15.5K which had a
negative effect on its interaction with the NUFIP223–260
fragment also had a negative effect on the interaction
with full-length NUFIP (Figure 1C). However, due its
lower stability the NUFIP223–260–15.5K interaction was
more drastically affected by mutations in 15.5K than the
full-length NUFIP–15.5K interaction. Nine of the tested
variants still interacted with NUFIP and NUFIP223–260,
whereas one (variant D) had lost these interactions.
Variant D carried three amino acid substitutions
(E74D75K76/AAA) in a highly conserved sequence of
the C-terminal part of helix a3 (Figure 1B). Next, by
using the same approach, we tested the importance of
each residue in the EDK sequence. The E74/A mutation
turned-out to be sufﬁcient to abolish the Y2H interaction
with both NUFIP and NUFIP223–260, whereas the D75/A
and K76/A mutations had no adverse effects (Figure 1C).
Interestingly, while several proteins of the L30 super-family
are able to recognize K-turn motifs in RNAs, conservation
of an E residue homologous to residue E74 in 15.5K is a
speciﬁc feature of proteins of the L7Ae family, namely,
15.5K/Snu13p, NHP2/Nhp2p and SBP2 (Figure 1B).
We also tested the impact on interaction of mutations in
other parts of the 15.5K helix a3. Residues E64, I65, H68
and L71 were of particular interest, since in the U4 snRNP,
E64, I65 and H68 were found to establish contacts with the
PRP31 Nop domain (25), and L71 is spatially close to E74
(Figures 1B and 3A). Variants E64/A, I65/A, H68/A and
L71/A still interacted with NUFIP, although the inter-
action was weaker for the L71/A variant (Figure 1C and
data not shown). When tested with NUFIP223–260, the E64/
A and I65/A 15.5K variants interacted with this small
motif, whereas the H68/A and L71/A variants had lost
the interaction (Figure 1C), reﬂecting the generally
weaker interactions of NUFIP223–260 compared to full-
length NUFIP. The weaker interaction observed for the
H68/A mutation might be due to destabilization of the
protein structure, not to abolition of a direct contact of
15.5K with NUFIP. Indeed, in the 15.5K 3D structure,
residue H68 points toward the center of the protein and
establishes an hydrogen bond with residue T43 of helix a2
(Figure 3A) (16) in contrast to residue L71 that is free of
interaction. Altogether, two main conclusions were drawn
from these data: (i) residue E74 of the 15.5K helix a3 is
essential for binding to NUFIP; and (ii) residue L71 likely
has some indirect or direct modulator effect on this
interaction.
The 15.5K E74D75K76/AAA mutant has an altered
intra-cellular localization and does not bind to NUFIP
in cellulo
Having shown the functional importance of residue E74 in
the E74D75K76 motif of 15.5K for formation of the
15.5K–NUFIP interaction in a heterologous system, we
then used a spatial recruitment assay in HeLa cells to
test its functional importance in an authentic in cellulo
context (Figure 2). The approach used was based on the
LacI/LacO system (41,65), which circumvents artifacts
occurring during co-immunoprecipitation assays, in par-
ticular, the loss of weak interactions or on the contrary the
re-association of proteins in the test tube. More precisely,
a HeLa cell line containing a tandem array of LacO sites
integrated in its genome was transfected with the mRFP1–
LacI–NUFIP expression vector. In the U2OS parental cell
line devoid of LacO sites, the fusion protein mRFP1–
LacI–NUFIP and WT NUFIP both had a diffuse local-
ization in the nucleoplasm and some weak nucleolar
staining (Figure 2A). When the GFP–15.5K fusion was
co-expressed with mRFP1–LacI–NUFIP in U2OS cells,
it localized in the nucleoli, Cajal bodies and nucleoplasm
as previously described, and no particular co-localization
was observed with mRFP1–LacI–NUFIP. In contrast, in
the cell line containing the LacO array, GFP–15.5K co-
localized with the bright spots formed by the binding of
mRFP1–LacI–NUFIP to the LacO sites. This indicated
that, as expected, NUFIP interacts with 15.5K in vivo.
We then tested the 15.5K E74D75K76/AAA variant in the
same assay (Figure 2B). In parental U2OS cells, the local-
ization of the mutant protein differed from its wild-type
counterpart. Consistent with a defect in its incorporation
into U4 and box C/D RNPs, the mutant 15.5K
accumulated at a lower level in nucleoli compared to
WT 15.5K and had a more diffuse localization throughout
the nucleoplasm and the cytoplasm. Moreover, in cells
containing mRFP1–LacI–NUFIP bound to the LacO
array, GFP–15.5K E74D75K76/AAA was unable to accu-
mulate at the LacO sites, indicating that it was defective
for NUFIP binding in vivo. Therefore, the data
demonstrated the importance of the extremity of helix
a3 of 15.5K for in cellulo binding of protein 15.5K to
NUFIP.
Then, for further characterization of the 15.5K/
Snu13p–NUFIP/Rsa1p interaction, we turned to S.
cerevisiae because of our capability to produce soluble
recombinant Snu13p and Rsa1p proteins in E. coli, and
the possibility to use yeast genetics to investigate the func-
tional importance of the Snu13p–Rsa1p interaction in
snoRNP assembly.
Amino acids in the Snu13p E74D75K76 motif are directly
involved in the Snu13p–Rsa1p interaction
We hypothesized that, like for 15.5K, some residues in the
Snu13p E72D73K74 motif located in the C-terminal part of
helix a3 (Figures 1 and 3A) were important for binding to
Rsa1p. Having in mind to get a clear demonstration of the
formation of a stoichiometric complex between the
proteins Snu13p and Rsa1p, we ﬁrst used co-expression
assays in E. coli to test this hypothesis. The His6-tagged
WT Snu13p and its His6-tagged E72D73K74/AAA variant
were each co-expressed with either full-length Rsa1p or its
C-terminal Rsa1p230–381 fragment, and complex formation
was investigated by Immobilized Metal Ion Afﬁnity
Chromatography (IMAC) (Figure 3B). Fractionation of
Nucleic Acids Research, 2014, Vol. 42, No. 3 2021
Downloaded from https://academic.oup.com/nar/article-abstract/42/3/2015/1057760
by UNIVERSITE LOUIS PASTEUR SERVICE COMMUN DE DOCUMENTATION user
on 06 February 2018
the IMAC puriﬁed proteins by SDS-PAGE revealed the
formation of a His6Snu13p–Rsa1p complex. Due to its low
level of structuration, Rsa1p was highly sensitive to pro-
teolysis in E. coli, as evidenced by mass spectrometry iden-
tiﬁcation of Rsa1p fragments migrating below full-length
Rsa1p in the SDS-PAGE fractionation (Figure 3B,
lane 2). However, taking into account these Rsa1p deg-
radation products, we estimated that interaction of Rsa1p
and its sub-fragments with Snu13p occurred with an
apparent 1:1 molar stoichiometry (Figure 3B, lane 2).
Snu13p also co-puriﬁed with Rsa1p230–381, but not with
the Rsa1p N-terminal domain (1-224) (data not shown).
No speciﬁc co-puriﬁcation of Rsa1p was detected with the
His6-tagged E72D73K74/AAA Snu13p variant (Figure 3B,
lane 4), which revealed the importance of residue(s) within
the EDK motif for the Snu13p–Rsa1p interaction.
Accordingly, when recombinant GST–Snu13p or
its E72D73K74/AAA variant were immobilized on
Glutathione Sepharose beads and incubated with the re-
combinant His6Rsa1p230–266 protein, GST–Snu13p
retained signiﬁcant amounts of His6Rsa1p230–266 protein
(Supplementary Figure S1, lane 6), whereas GST alone
or the E72D73K74/AAA Snu13p variant did not
(Supplementary Figure S1, lane 8).
At this stage of the study, two explanations could be
proposed for these data: either mutation of the E72D73K74
motif altered the overall Snu13p conformation and conse-
quently abrogated the interaction with Rsa1p, or the
Snu13p E72D73K74 motif was directly involved in the
interaction. By providing information on the a-helix
content of proteins, far UV CD spectroscopy can reveal
conformational changes occurring upon generation of
Figure 2. 15.5K E74A does not bind NUFIP in vivo and is not efﬁciently incorporated into RNPs. (A) U2OS and U2OS LacO cells were transfected
with mRFP–LacI–NUFIP and either GFP–15.5K, (B) or its EDK->AAA variant. WT 15.5K accumulates in nucleoli, in Cajal bodies and is also
diffusely present in the nucleoplasm (top left panel). When mRFP1–LacI–NUFIP accumulates at the LacO sites, WT 15.5K is also enriched there
(see insets in the top panel). In contrast, while the mutant 15.5K is also present in nucleoli, Cajal bodies and in the nucleoplasm, it is also present in
large amount in the cytoplasm, indicating a defect in RNP assembly (bottom-left panel). In addition, this mutant fails to be recruited to the LacO
sites by mRFP–LacI–NUFIP (bottom panels).
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Figure 3. The E72D73K74/AAA mutation in Snu13p abolishes Snu13p–Rsa1p interaction without major alteration of the protein structure.
(A) Comparison of the 15.5K and Snu13p protein structures. 3D structure representations of the complex formed between human protein 15.5K
and the 50 stem-loop of U4 snRNA (PDB accession number: 1E7K) (16), and of the S. cerevisiae Snu13p protein (PDB accession number: 2ALE)
(15) were obtained by using the PyMOL software (66). The residues of the C-terminus of helix a3, which are conserved in the two proteins, are
indicated by black letters. On the U4-–15.5K structure, residues in pink interact with PRP31 in the U4–15.5K–PRP3178–333 complex (25). Alanine
substitutions in the Snu13p variant used in the experiments of this ﬁgure are displayed in the insert. (B) The E72D73K74/AAA mutation in Snu13p
abolishes Snu13p–Rsa1p interaction in E. coli co-expression assays. The wild type or mutated His-tagged protein Snu13p was co-expressed in E. coli
with full-length Rsa1p. His-pull down assays from the crude cellular extracts were performed using IMAC. The soluble fraction (Input= In) and the
puriﬁed proteins (Eluate=E) were fractionated by SDS-PAGE and revealed by Coomassie blue staining. The molecular weight ladder (L) is shown
on the left. (C) Comparative CD analysis of WT Snu13p and its E72D73K74/AAA variant reveals limited effects of the substitution on the protein
structure. WT and variant Snu13p were dissolved at a 4 mM concentration in 10mM Tris-Hcl buffer, pH 7.8, 150mM NaCl and CD spectra were
collected from 200 to 260 nm. (D) The E72D73K74/AAA substitution in Snu13p abolishes its interaction with Rsa1p230–266 as evidenced by CD. A
two-compartment cuvette was used and CD spectra were recorded from 205 to 260 nm prior and after mixing the material in the two compartments,
as described in ‘Materials and Methods’ section. The CD spectra recorded before mixing the samples are represented in dark blue, and the spectra
recorded after mixing the samples are in dark green.
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mutations in proteins or upon their interaction with a
partner. As Snu13p predominantly folds into a-helices
(15), this approach was perfectly adapted to test whether
the E72D73K74/AAA mutation modiﬁed the Snu13p sec-
ondary structure. Consistent with the hypothesis of a
physical interaction of the Snu13p E72D73K74 motif with
Rsa1p, the CD spectra of WT Snu13p and its E72D73K74/
AAA variant recorded from 200 to 260 nm were very
similar (Figure 3C). Another argument in favor of a
direct interaction was obtained by using a two compart-
ments CD cuvette (Figure 3D): one was ﬁlled with Snu13p
or its variant and the other one with His6Rsa1p230–266 at a
protein to peptide molar ratio of 1. CD spectra were
recorded from 205 to 260 nm before and after mixing the
contents of the two compartments. When using WT
Snu13p, the intensity of the signal at 222 nm was
modiﬁed after mixing, which was indicative for the forma-
tion of a direct interaction between the two partners
(Figure 3D, left panel). In contrast, no variation at
222 nm was detected when the Snu13p E72D73K74/AAA
variant was used (Figure 3D, right panel), reﬂecting its
inability to interact physically with His6Rsa1p230–266.
Therefore, by using biochemical and biophysical
approaches, we demonstrated: (i) the formation of a
direct Snu13p–Rsa1p interaction at a 1:1 molar ratio; (ii)
the direct involvement of some amino acids in the
E72D73K74 motif in this interaction. In addition, we de-
veloped a CD-based assay to test for the Snu13p–Rsa1p
interaction.
Residue E72 in the Snu13p EDK motif plays a key role in
the Snu13p–Rsa1p interaction
Then, to delineate which of the three EDK amino acids
was/were important for the Snu13p–Rsa1p interaction, we
came back to the Y2H approach (Figure 4A). As expected
from previous results (2), WT Snu13p interacted with both
full-length Rsa1p and its C-terminal half (Rsa1p230–381).
No interaction was detected with either the Snu13p
E72D73K74/AAA variant or the Snu13p E72/A variant,
whereas the D73/A and K74/A mutations had no marked
deleterious effects on the interaction (data not shown).
Therefore, as found for protein 15.5K, the E72 residue
in the Snu13p EDK motif is required for interaction
with Rsa1p. We completed these data by perform-
ing gel-shift assays with the U14 snoRNA–Snu13p
complex (Figure 4B). As previously observed (2),
Rsa1p230–381 and Rsa1p230–266 super-shifted the complex
formed by Snu13p and an in vitro transcribed U14 box
C/D snoRNA (Figure 4B, lanes 3 and 4). In contrast, it
did not super-shift this complex, when the Snu13p
E72D73K74/AAA or the E72/A variants were used
(Figure 4B, lanes 7, 8, 11 and 12). Therefore, this
residue is necessary for interaction of both free and
snoRNA-bound Snu13p with Rsa1p.
As these experiments demonstrated the major role
of residue E72 of the Snu13p EDK motif for
interaction with Rsa1p, we decided to determine which
amino acid(s) in Rsa1p can be the partner(s) of this
residue.
Rsa1p conserved residues W245 and R249 are required for
binding to Snu13p
Alignment of the human NUFIP223–260 and yeast
Rsa1p230–266 amino acid sequences revealed the presence
of only one strictly conserved amino acids stretch
(W245R246E247E248R249) (Supplementary Figure S2). We
guessed that it might be important for the Snu13p–
Rsa1p interaction. To test this hypothesis, we substituted
individually most of its residues by alanines in the
Rsa1p230–266 protein (Figure 5A). The effect on the
Figure 4. Residue E72 in Snu13p plays a key role in the Snu13p–Rsa1p
interaction. (A) The E72/A Snu13p variant does not interact with Rsa1p
in Y2H assays. In the Y2H assays Snu13p or its variants were used as
the bait, whereas Rsa1p or its minimal functional fragment Rsa1p230–
381 was used as the prey. A control was performed with an empty
pACT2 vector (–). Cell were grown on solid glucose medium lacking
histidine, in the presence of 3-Amino-1,2,4-triazol (3AT) at a 20, 30, 40
or 50mM concentration. 3AT is competitive inhibitor of the HIS3
reporter gene product. The presence of colonies is indicative of a
protein–protein interaction. (B) The E72/A mutation in Snu13p
abolishes the capability of Rsa1p230–381 and Rsa1p230–266 to interact
with the Snu13p–U14 snoRNA complex. Radiolabeled U14 snoRNA
was incubated with WT Snu13p or one of its a3 helix variants and His-
tagged Rsa1p230–381 or Rsa1p230–266 in conditions described in
‘Materials and Methods’ section. GST was used as a negative
control. The complexes formed were fractionated by gel electrophoresis.
Positions of the Snu13p–U14 RNA (RNP1), Rsa1p230–266–Snu13p–U14
RNA (RNP2) and Rsa1p230–381–Snu13p–U14 RNA (RNP3) complexes,
as well as, of the free U14 RNA (U14) are indicated on the left side of
the autoradiogram.
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Figure 5. The Rsa1p residues R249 and W245 are essential for Snu13p interaction with full-length Rsa1p. (A) The conserved W239R240E241E242R243
amino acid sequence of Rsa1p230–266, is conserved in NUFIP. Amino acid substitutions in the variant used in the experiments of this ﬁgure are shown
in red. (B) Substitutions of residues W245, R246 or R247 by an alanine in His6Rsa1p230–266 abolish its interaction with Snu13p as evidenced by CD. As
in Figure 3, a two-compartment cuvette was used and CD spectra were recorded from 205 to 260 nm prior (blue) and after mixing (green) the
material in the two compartments. (C) Residues W245, R246 and R249 in Rsa1p are needed to bind the Rsa1p230–266 fragment to the Snu13p–snoRNA
U14 complex. Radiolabeled U14 snoRNA was incubated with WT Snu13p and WT or mutated His-tagged Rsa1p230–266, in conditions described
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interaction with Snu13p was assessed (Figure 5B), using as
reporter signal, the speciﬁc modiﬁcation of the CD signal
at 220 nm observed upon formation of the Snu13p–
Rsa1p230–266 complex (Figure 3D). Although the
decrease in the CD signal at 222 nm observed for associ-
ation of the E247/A variant with Snu13p was similar to
that found for WT Rsa1p230–266, no modiﬁcation of this
signal was detected when mixing the Rsa1p230–266 W245/A,
or R246/A, or R249/A variants with Snu13p (Figure 5B).
These data strongly suggested the direct involvement of
residues W245, R246 and R249 in the Snu13p–Rsa1p230–266
interaction. Accordingly, when we tested the ability of
these four Rsa1p230–266 variants to form trimeric
complexes with Snu13p and snoRNA U14 by gel-shift
assays, only the Rsa1p230–266 E247/A variant super-
shifted the Snu13p–U14 RNA complex (Figure 5C,
lane 6).
Interestingly, when the same amino acid substitutions in
the WREER motif were generated in a longer Rsa1p
fragment (Rsa1p230–381) and their ability to abolish the
interaction with Snu13p was tested by Y2H assays, only
the W245/A and R249/A substitutions were found to impair
the Y2H interaction (Figure 5D). The R246/A substitution
had no visible effects, suggesting that as found
for the 15.5K–NUFIP interaction (Figure 1C), the
Snu13p–Rsa1p230–266 interaction is less stable than the
Snu13p–Rsa1p230-–381 interaction and that residue R246
may be involved in the interaction but is not essential.
Similarly, when we co-expressed the WT or variant
Rsa1p or Rsa1p230–381 proteins with His6Snu13p in
E. coli, and co-puriﬁed His6Snu13p with its associated
proteins by IMAC, the R249/A substitution in both full-
length Rsa1p and Rsa1p230–381 abolished the speciﬁc inter-
action with Snu13p, whereas the R246/A variant retained
binding activity (Figure 5E).
Hence, our data identiﬁed three residues in Rsa1p
(W245, R246 and R249) that may be located at the interface
with Snu13p, and revealed a key role of W245 and R249 and
a less signiﬁcant role for R246 in this interaction. As the
important residue in Snu13p was found to be a glutamate
residue (E72), it was reasonable to ﬁnd that an arginine
residue (R249), which can establish electrostatic inter-
actions, plays a key role in the partner protein. It was
then important to test whether the Snu13p and Rsa1p
residues found to have a role in the Snu13p–Rsa1p inter-
action have an importance for yeast cell growth and for
C/D box snoRNP assembly.
The amino acids essential for the Snu13p–Rsa1p
interaction are important for cell growth
Deletion of the RSA1 gene in S. cerevisiae leads to a
growth defect, especially at high temperature (45).
Hence, we tested whether abolition of the Snu13p–
Rsa1p interaction can generate a similar growth pheno-
type. To this end, we used a yeast strain containing the
chromosomal SNU13 ORF placed under the control of
the conditional GAL1 promoter. These cells were trans-
formed with a centromeric pG1 plasmid allowing consti-
tutive expression of the WT or mutant Snu13p protein and
cell growth was monitored in liquid media (Table 1A). In
the presence of glucose in the medium (absence of expres-
sion of the genomic SNU13 gene), a doubling time of
3.26 h was observed for the ectopic expression of WT
Snu13p from the pG1 plasmid. This doubling time was
increased to 3.56 and 3.58 h, respectively, when
the E72D73K74/AAA and E72/A Snu13p variants were
expressed. Although, the increase was not strong, it was
reproducibly observed, and supported the idea of a func-
tional importance of the identiﬁed Snu13p–Rsa1p inter-
action, and in particular, of the Snu13p residue E72
involved in this interaction. To complete the demonstra-
tion of a functional role of the Snu13–Rsa1p interaction,
WT and variant Rsa1p proteins were expressed from a
centromeric plasmid in an RSA1 KO strain, and growth
rates were measured (Table 1B). The KO strain had a
doubling time 44% slower compared to WT cells.
Ectopic expression of Rsa1p restored the wild-type
growth rates (2.6 h). In contrast, only a partial restoration
of cell growth was obtained for the Rsa1p R249/A and
W245/A variants that did not bind to Snu13p (doubling
time of 3.24 and 3.06 h, respectively).
The R246/A substitution in Rsa1p, which did not
abolish binding to Snu13p, had a more limited effect on
cell growth. Therefore, substitutions of the three amino
acids which play a key role in the Snu13p–Rsa1p inter-
action all have a negative effect on yeast cell growth
showing the functional importance of the identiﬁed
interaction.
The Rsa1p residue R249, essential for the Snu13p–Rsa1p
interaction, is important for box C/D snoRNA stability
As defects in snoRNA assembly are known to lead to
partial degradation of snoRNAs (2,3), we guessed that if
the Snu13p–Rsa1p interaction plays an important role for
snoRNP assembly, its abolition in vivo should lead to a
decreased level of cellular snoRNAs. To test this hypoth-
esis, we used northern blot analyses to evaluate the steady-
state levels of a selected number of box C/D snoRNAs in
the RSA1 S. cerevisiae strain Y190 carrying an RSA1
gene disruption, its isogenic strain with an active RSA1
gene, and in the RSA1 strain complemented by ectopic
expression of WT or R249/A Rsa1p protein. The selected
snoRNAs included U14 which is involved in both pre-
rRNA 20-O methylation and its early endo-nucleolytic
Figure 5. Continued
in ‘Materials and Methods’ section. The complexes formed were fractionated by gel electrophoresis. Positions of the Snu13p–U14 RNA (RNP1) and
Rsa1p230–266–Snu13p–U14 RNA (RNP2) complexes, as well as, of free U14 RNA (U14) are indicated on the left side of the autoradiogram. (D) The
Rsa1p residues W245 and R249 are required for interaction of Snu13p with the Rsa1p230–281 fragment in Y2H assays, but not residue R246. In the Y2H
assays, Snu13p was used as the bait, and the WT or variant Rsa1p230–381 fragments as the prey. The 3AT inhibitor was used at concentrations
comprised between 10 and 50mM. (E) The R249/A mutation in full-length Rsa1p abolishes Snu13p–Rsa1p interaction in co-expression assays,
whereas the Rsa1p R246/A variant retains some capability to interact with Snu13p in these assays. Co-expression and co-puriﬁcation assays were
performed in the same conditions as in Figure 3B, using either full-length Rsa1p or Rsa1p230–381 variants.
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cleavage steps leading to 18S rRNA (67,68), and
snoRNAs U18, snR63, snR190, snR45 and snR13,
which are only involved in 20-O methylations of the pre-
rRNA (68). The results obtained conﬁrmed that disrup-
tion of the RSA1 gene is associated to a drastic decrease of
the amounts of most of the tested C/D box snoRNAs
(snR63, snR190, snR45, snR13 and U18) (Figure 6).
Ectopic expression of WT Rsa1p restored normal
snoRNA amounts, whereas the expression of the variant
R249/A Rsa1p protein did not. Among the tested RNAs,
only U14 snoRNA showed a lower decrease in the absence
of Rsa1p expression that is restored upon expression of
the Rsa1p R249/A variant. Due to its essential role in 18S
rRNA production, U14 may have a longer life span than
the other box C/D snoRNAs tested, or the assembly of the
U14 snoRNP may be less dependent upon the Snu13p–
Rsa1p interaction. In contrast, the decreased levels of
snoRNAs snR63, snR190, snR45, snR13 and U18 are
likely indicative of a decreased efﬁciency of their
assembly into snoRNPs. Therefore, our data strongly sup-
ported the idea of a functional importance of the Snu13p–
Rsa1p interaction for box C/D snoRNP biogenesis and as
a consequence for yeast cell growth. To go one step
further in understanding the snoRNP assembly process,
we tested whether abolition of this interaction may
impair the recruitment of other components of the
snoRNP assembly machinery.
Residue E72 in Snu13p is required for recruitment of the
Pih1–Tah1p dimer on a snoRNA in in vitro assays
We had previously shown that Rsa1p230–381 interacts with
Pih1p, an integral component of the R2TP complex (2),
and had proposed that through this interaction with Pih1p
and its interaction with Snu13p, Rsa1p tethers the R2TP
complex onto Snu13p bound to the snoRNA. Our identi-
ﬁcation of a Snu13p residue required for the Snu13p–
Rsa1p interaction (E72) opened us the possibility to test
the importance of this interaction for the recruitment of
Pih1p on a box C/D snoRNA in in vitro experiments. For
this purpose, as protein Pih1 has a strong tendency to
aggregate and to be degraded when produced alone in
E. coli, we produced a His6Tah1p–Pih1p complex by co-
expression of the two proteins in E. coli, and puriﬁed the
complex on Ni-Sepharose beads (69). Then, we tested the
capability of interaction of this complex with 32P labeled
U14 snoRNA in the presence or the absence of the WT
recombinant Rsa1p230–381 C-terminal domain and of the
recombinant WT Snu13p protein or its E72/A variant.
Retention of U14 snoRNA on the beads was detected
by autoradiography after electrophoresis on a denaturing
gel. As shown in Figure 7A, very little amounts of RNA
were co-puriﬁed with the His6Tah1p–Pih1p in the absence
or the presence of Snu13p alone, showing a weak capacity
of the His6Tah1p–Pih1p to form a stable complex with U14
snoRNA alone or the Snu13p–U14 complex. In contrast,
in the presence of the Rsa1p230–381 C-terminal domain,
retention of the snoRNA was substantially improved,
indicating that this domain of Rsa1p can mediate the
recruitment of the Tah1p–Pih1p complex on the
Snu13p–U14 complex. Accordingly, when using the E72/
A Snu13p variant which does not interact with Rsa1p,
only a background level of RNA was detected on the
beads (Figure 7B). Thus, the Snu13p–Rsa1p interaction,
Table 1. Residues E72 in Snu13p and residues W245 and R249 in
Rsa1p are required for optimal yeast cell growth
(A)
Strain Gal::SNU13 G (h) Growth
defect (% WT)
pG1::SNU13-WT 3.26±0.04
pG1::SNU13-E72D73K74/AAA 3.56±0.05 –9.2
pG1::SNU13-E72/A 3.58±0.09 –9.8
pG1::SNU13-L69/A 3.22±0.09 +1.2
(B)
Strain RSA1 G (h) Growth
defect (% WT)
pG1::(-) 3.74±0.18 –44.2
pG1::RSA1-WT 2.6±0.13
pG1::RSA1-W245/A 3.06±0.10 –17.8
pG1::RSA1-R246/A 2.55±0.10 +1.7
pG1::RSA1-R249/A 3.24±0.03 –24.8
(A) Effects of ectopic expression of WT or variant Snu13p proteins
from recombinant pG1::SNU13 plasmid on growth of YPH499-
GAL::SNU13 yeast cell. YPH499-GAL::SNU13 cells were transformed
with recombinant pG1::SNU13 plasmids expressing WT or mutated
Snu13p. Transformed cells were grown at 30C in YPD medium con-
taining glucose in order to block genomic expression of Snu13p. Cells
were maintained in exponential growth by successive dilutions. The
effects of the ectopic expression of WT and mutated Snu13p on cell
growth were monitored by measuring the absorbance at 600 nm. The
cell doubling times (G) were calculated and are expressed in hours
(second column). Estimated errors on the G-values were calculated
from three distinct experiments performed in the same conditions.
G-values were used to calculate a growth defect percentage for each
variant Snu13p protein (third column). (B) Effects of the ectopic ex-
pressions of WT and variant Rsa1p from recombinant pG1::RSA1
plasmid on growth of an RSA1 KO strain. Same legend as in panel A.
Figure 6. The Rsa1p residue R249 is required for full assembly of
several yeast box C/D snoRNPs. The steady-state levels of a selected
series of box C/D snoRNAs were measured by northern blot analysis in
total extracts from RSA1 KO yeast cells expressing either WT Rsa1p or
its R249/A variant from the pG1::RSA1 plasmid. The speciﬁc 5
0 end
labeled DNA probes used for each snoRNA are given in ‘Materials and
Methods’ section.
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and in particular the E72 Snu13p residue, is required for
binding of the R2TP complex to pre-snoRNP complexes.
This observation likely explains the decreased amounts of
snoRNAs that we detected in yeast strains with an
impaired Snu13p–Rsa1p interaction.
Having shown that some residues involved in the
Snu13p–Rsa1p interaction are required for yeast growth
and more precisely for snoRNP assembly, we turned to
structural approaches to better understand the assembly
process.
Rsa1p includes an alpha helix able to bind Snu13p
The solution structure of Snu13p had been solved by
X-ray crystallography (15). In contrast, no 3D structure
was available for Rsa1p. As the Rsa1p230–266 fragment
was not soluble enough for NMR studies, we looked for
suitable Rsa1p230–266 minimal sub-fragments. Firstly, we
found by in vivo Y2H approach that Rsa1p238–261 was
sufﬁcient for interaction with Snu13p (Table 2).
Secondly, we show by isothermal titration calorimetry
(ITC) that the synthetic peptide Rsa1p238–259 was able to
bind Snu13p in vitro with a dissociation constant value of
18±1 mM (Supplementary Figure S3). These data suggest
that the two last residues of the previous determined Y2H
fragment are not essential in the interaction. Finally, the
solubility of this Rsa1p238–259 fragment was compatible
with 3D structure analysis by NMR spectroscopy, and it
contained the residues described above as being involved
in Snu13p binding. Based on the clear NMR data col-
lected, we could unambiguously assign most of the reson-
ances obtained for this peptide and determine its 3D
structure in solution. A schematic view of the NMR
distance restraints and structural statistics for the calcula-
tion are displayed in Supplementary Figure S4 and
Supplementary Table S1, respectively. As shown by the
superimposition of the 10 structures having the lowest
energies (Figure 8A), Rsa1p238–259 is folded into a a-helix.
In agreement with our functional analysis, in the
established structure, the side-chains of residues R246,
and of the two residues W245 and R249 which play a key
role in the Snu13p interaction, are positioned on the same
face of the helix, in a conﬁguration favorable for the es-
tablishment of interactions with Snu13p amino acids
(Figure 8B).
As residues V242, K250, W253, K256 and I257 were also
located on the same face of the Rsa1p helix (Figure 8B),
some of them might also interact with Snu13p. Thus, we
decided to test the effects of their substitutions into
Table 2. Y2H assays between Snu13p and Rsa1p sub-fragments or their variants
Rsa1p fragments/mutants Sequences Y2H interaction with Snu13p
After 3 days After 5 days
238–252 TDEDVKKWREERKKM – –
238–256 TDEDVKKWREERKKMWLLK – –
238–261 TDEDVKKWREERKKMWLLKISNNK ++ ++
238–264 TDEDVKKWREERKKMWLLKISNNKQKH ++ ++
238–261 V242/A TDEDAKKWREERKKMWLLKISNNK ++ ++
238–261 K250/A TDEDVKKWREERAKMWLLKISNNK ++ ++
238–261 K251/A TDEDVKKWREERKAMWLLKISNNK ++ ++
238–261 W253/A TDEDVKKWREERKKMALLKISNNK – –
238–261 K256/A TDEDVKKWREERKKMWLLAISNNK – +
238–261 I257/A TDEDVKKWREERKKMWLLKASNNK – –
238–261 K261/A TDEDVKKWREERKKMWLLKISNNA ++ ++
The sequences encoding fragments of Rsa1p (Partner A) and the sequence encoding Snu13p (Partner B) were fused to Gal4AD and Gal4BD,
respectively. After 3 and 5 days of yeast growth on Leu–/Trp–/His– selective media, the interaction was scored by eye, using the number of positive
clones.
Figure 7. Interaction of Snu13p with the Rsa1p230–281 fragment is
required for recruitment of the Tah1p–Pih1p complex on the
Snu13p–U14 snoRNA complex. (A) Rsa1p230–381 is required for efﬁ-
cient association of the Snu13p–U14 snoRNA complex on the
His6Tah1p–Pih1p complex. The radiolabeled U14 snoRNA was
incubated with the recombinant Snu13p protein and the His6Tah1p–
Pih1p dimer bound to Ni-Sepharose beads, in the absence or the
presence of an increasing concentration of Rsa1p230–381 fragment
(from 0.25 to 2 mM). The RNAs retained on the beads were analysed
by denaturing gel electrophoresis. The input corresponds to 10% of the
total quantity of radiolabeled RNA used in the binding assays (left
lane). A control assay was performed in the absence of Snu13p
(second lane). (B) The E72 mutation in Snu13p which abolishes the
Snu13p–Rsa1p230–281 interaction abrogates the recruitment of the
Snu13p–U14 snoRNA complex on the Tah1p–Pih1p complex. His-
pull down experiments and analysis of the retained U14 snoRNA
were performed as in panel A, using the WT Rsa1p230–281 fragment
at a 2mM concentration, and either WT Snu13p or its E72/A variant
at a 1mM concentration.
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alanine on the stability of Snu13p–Rsa1p interaction by
Y2H experiments (Table 2). As expected, the control sub-
stitution of K251 residue located on the opposite side of the
helix had no effect on the Y2H signal (Table 2). In
contrast, individual substitutions of residues W253, I257
abolished the Y2H signal, strongly suggesting that these
residues also have an important role in the interaction.
The K256/A substitution limited but did not abolished
the Y2H signal, and substitutions of residues V242 and
K250 had no detectable effects (Table 2). Therefore, the
structure we solved for fragment Rsa1p238–259 helped us
to identify two additional Rsa1p residues (W253 and I257)
expected to be important for the Snu13p–Rsa1p inter-
action and they suggested that residue K256 may also be
involved.
Unfortunately, the intermediate exchange regime
between Snu13p and Rsa1p238–259 gave rise to low
quality NMR spectra (data not shown). This low quality
avoided us to perform an experimental determination of
the 3D structure of the Snu13p–Rsa1p238–259 complex by
the NMR approach. Nevertheless, one possibility to get
some structural information on the Rsa1p–Snu13p inter-
face was to use in silico docking of the established
structures.
3D structure modeling of the Snu13p–Rsa1p238–259
interface reveals both electrostatic and hydrophobic
interactions
To build a 3D model of the Snu13p–Rsa1p238–259 inter-
action, we docked the NMR structure established for
Rsa1p238–259 onto the crystal structure of Snu13p by
using Haddock 2.1/CNS 1.21 (58,59) (PDB accession
number: 2ALE, (15)). We introduced the knowledge we
gained from the various experiments described above to
drive the docking experiment (see ‘Materials and
Methods’ section). Results of the docking procedure are
presented in Table 3. According to energy and RMSD
values calculated for the 10 models with the lowest
Haddock scores, Rsa1p238–259 is predicted to adopt a pref-
erential positioning on Snu13p in which the N-terminal
part of the peptide is close to the EDK motif of the
protein, whereas the C-terminal part accommodates into
the groove formed by helix a3 and the N-terminal part of
Snu13p (Figure 8C).
The best model deﬁned by the Haddock scores
(Figure 8D and E) can explain the role in the Snu13p–
Rsa1p interaction of the Snu13p E72 and the Rsa1p R249
residues found to be required for optimal yeast cell
growth. Indeed, in this model, the carboxylate groups of
Figure 8. The Rsa1p238–259 NMR structure and modeling of the Snu13p–Rsa1p interaction show both electrostatic and hydrophobic components at
the protein–protein interface. (A) Backbone superimposition of the 10 best structures of Rsa1p238–259. (B) Side-chains representation of the lowest
energy Rsa1p238–259 structure. The helical conformation is highlighted using a cartoon representation. The hydrogen atoms are not represented.
(C) Ribbon representation of the 10 3D models with the lowest haddock score resulting from the docking of the lowest energy NMR structure of
Rsa1p238–259 on the X-ray structure of Snu13p. (D) Ionic interaction network between R246, R249 and K250 in Rsa1p238–259 and E72 and D73 in
Snu13p. (E) Highlight of the Snu13p pocket hosting the W253 in Rsa1p238–259. The ﬁgures have been done with PyMOL software (66).
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residues E72 and D73 in Snu13p are involved in a network
of electrostatic bonds with the side-chains of residues R246,
R249 and K250 in Rsa1p238–259 and the position of R249 is
frozen through hydrogen bonding with the hydroxyl
group of residue Y78 in Snu13p (Figure 8D). According
to our model, the Rsa1p W245 residue shields the electro-
static network of interactions around E72 from the solvent,
which may explain its role in the interaction and its need
for optimal cell growth. The last Y2H assays have pointed
out the possible importance of the Rsa1p residues W253
and I257 and to a lesser extent K256 in the Snu13p–
Rsa1p238–259 interaction. One explanation for the import-
ance of residue W253 can be its participation to strong
hydrophobic interactions. Indeed, according to our
model, its indol ring points into a large pocket formed
by the aliphatic side-chains of the Snu13p residues K7,
F9, L65 and L69 (Figure 8E). Concerning residues K256
and I257, through their long side-chains they enclose
residue W253 in a cage favorable for hydrophobic inter-
actions with residues of the Snu13p hydrophobic pocket.
The stability of the proposed model in an aqueous
medium as tested by a 5-ns Molecular Dynamic simula-
tion (see ‘Materials and Methods’ section) shows that
the overall 3D structure of the model does not undergo
drastic changes. The network of ionic interactions still
exists during the 5 ns of simulation (mean RMSD value
of 1.41±0.26 A˚ compared to the initial haddock struc-
ture) and the location of the side-chain of W253 in
the Snu13p pocket described above is stable over time
(analysis of the trajectory calculated with NAMD is avail-
able as Supplementary Table S2). Therefore, to assess
the stabilizing effect generated by binding of W253 in the
Snu13p hydrophobic pocket, we substituted one of the
hydrophobic residues of this pocket, L69, by an alanine
residue. The choice of L69 was dictated by our Y2H
results with the human proteins and by its close vicinity
to the Rsa1p W253 residue (Figure 8E). The effect of the
mutation on the Snu13p–Rsa1p230–266 binding was tested
by EMSA experiments. As illustrated in Figure 9, the
L69/A mutation abolished the binding of Rsa1p230–266 to
the Snu13p–U14 RNA complex, demonstrating the
in vitro stabilization effect of the Snu13p residue L69 on
the Snu13p–Rsa1p230–266 interaction. These data are in
good agreement with our ﬁnding of a role of the human
15.5K residue L71 (the counterpart of L69 in Snu13p) in
the NUFIP223–260–15.5K interaction (Figure 1C).
DISCUSSION
Several proteins have been proposed to participate in box
C/D snoRNP biogenesis. However, little is known on their
mechanism of action. NUFIP and its yeast homolog
Rsa1p were identiﬁed as key factors in the biogenesis of
RNPs containing proteins of the L7Ae family and were
found to interact with proteins 15.5K and Snu13p,
respectively (2). Based on previous data, the 15.5K–
NUFIP and Snu13p–Rsa1p interactions were expected
to facilitate recruitment of the HSP90-R2TP complex.
Accordingly, in the absence of NUFIP and Rsa1p, a
marked decrease of the box C/D snoRNP levels has
been observed (2).
Here, by combination of molecular and cellular
analyses, we were able to identify some of the amino
acids located at the Snu13p–Rsa1p and 15.5K–NUFIP
interfaces and their mutation highlighted for the ﬁrst
time the crucial role of these interactions for box C/D
snoRNP assembly. This prompted us to use structural
approaches to improve our knowledge on the Snu13p–
Rsa1p interface and we propose a 3D structure model of
this interaction. Our data bring insights on how NUFIP
and Rsa1p can discriminate L7Ae members within the
larger L30 protein super-family and suggest a function
for NUFIP/Rsa1p in inhibiting activity of immature
snoRNPs.
A stable Snu13p–Rsa1p interaction is required for efﬁcient
assembly of C/D box snoRNPs in yeast
For the ﬁrst time, we show in cellulo effects of mutations
abolishing the 15.5K–NUFIP and Snu13p–Rsa1p
Table 3. List of interacting residues and structural analysis for the 10
best Snu13p-Rsa1p238–259 structures of the Haddock 2.1 results
Snu13p Rsa1p238–259
Active residues P6 K7 F9 L65
L69 E72 D73
V242 W245 R246
R249 K250 W253
K256 I257
Passive residues E62 P68 N75
Semi-ﬂexible segments Automated mode T238–N259
Docking results
RMSD from mean structure (A˚)
All backbone atoms 1.01±0.40
All heavy atoms 1.36±0.41
Energies (kcal/mol)
E.inter –434±33
E.vdw –33±8
E.elec –417±36
Buried surface area (A˚2) 1223±66
Number of AIR violation (>0.3 A˚) 1±0.4
Figure 9. Residue L69 in Snu13p participates in vitro in the interaction
of the Rsa1p230–266 fragment with Snu13p. Formation of the U14
RNA–Snu13p–Rsa1p230–266 complexes and analyses by gel-shift assays
were as in Figure 4B. Positions of the RNP1 and RNP2 complexes and
of the free U14 RNA are indicated as in Figure 4B.
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interactions. The 15.5K mutant protein unable to bind
NUFIP shows a substantially altered intra-cellular local-
ization, with a stronger cytoplasmic signal that suggests a
partial defect in incorporation into U4 and C/D RNPs
(Figure 2). In yeast, deletion of the RSA1 gene was
known to induce a marked temperature sensitive pheno-
type (45). However, as Rsa1p had been proposed to have
several functions (45), it was difﬁcult to assign the cause of
the observed growth defect. Here, based on our detailed
analysis of the Snu13p–Rsa1p interaction, we could create
point mutations in Snu13p and Rsa1p, and dissect the
functional importance of electrostatic and Van der
Waals interactions formed at the Snu13p–Rsa1p interface.
Point mutation of residue E72 in Snu13p increased the
cell doubling time by a factor of 10%, whereas point
mutations of residue R249 and W245 in Rsa1p increased
the cell doubling time by factors of 25 and 18%, re-
spectively. This indicates that the electrostatic interactions
developed by residues E72 (Snu13p) and R249 (Rsa1p) play
important roles in vivo. We can reasonably assume that
one of these roles consists in enabling the recruitment of
Rsa1p on pre-snoRNPs and therefore the association of
the R2TP complex and other snoRNP core proteins on
pre-snoRNPs. In agreement with this statement, we
showed that in vitro binding of the Tah1p–Pih1p dimer
to pre-snoRNP is dependent on the presence of Rsa1p
and that mutation of residue E72 in Snu13p impairs this
binding (Figure 7). Also consistent with this statement, the
level of box C/D snoRNAs after R249/A substitution in
Rsa1p was very similar to that found upon deletion of the
RSA1 gene: the snR13 and snR63 snoRNAs were un-
detected in the two types of mutant cells. The stronger
effect on yeast growth of mutations in Rsa1p compared
to mutations in Snu13p suggests that the Rsa1p amino
acids involved in the Snu13p binding may also be
involved in the interaction with other target proteins.
Interestingly, however, the effect of deletion or muta-
tions of the RSA1 gene on the U14 snoRNA steady-state
was low, which may either results from a greater stability
of this RNA or from the lower dependence of the U14
snoRNP assembly on Rsa1p. Therefore, we cannot
exclude the possibility that some of the yeast snoRNAs
can be efﬁciently assembled without the help of the
assembly machinery. Accordingly, in plants, atNUFIP
has an effect that is speciﬁc for box C/D snoRNAs
encoded by polycistronic not monocistronic genes (70).
NUFIP and Rsa1p discriminate L7Ae members through
helix a3
Prior to the present study, very little was known about
amino acids required for discrimination of ‘L7Ae-like’
proteins by the platform proteins Rsa1p and NUFIP.
Previous studies proposed the involvement of the 15.5K
E124 and R125 residues in NUFIP recruitment (22,46). The
present data invalidate this conclusion, because we show
that the E124R125/SS mutant has the capability to interact
efﬁciently with NUFIP and the small NUFIP223-–260
domain in Y2H assays (Mut I in Figure 1C). The
absence of conservation of the E124 and R125 15.5K
residues in protein Snu13p also makes it very unlikely
that they participate to an interaction expected to be
conserved from yeast to human. Thus, the effect previ-
ously observed was likely to be indirect.
The E74D75K76N77/RKMT mutation in Snu13p was
also found to abrogate detection of the 15.5K–NUFIP
association in a cellular extract (46), but this inability
has been attributed to an improper folding of this 15.5K
variant, possibly because of the large diversity of amino
acid substitutions used (25). To avoid such structural
defect, in the present study the amino acids in the three
EDK residues were substituted by alanine residues, which
are unable to establish stable interactions with other
residues in the protein. In addition, the EDK residues in
15.5K and Snu13p (15,16) do not develop internal inter-
actions, and no major modiﬁcation of the protein struc-
ture was thus expected upon their mutation into AAA and
this was conﬁrmed by our CD data (Figure 3C). Thus, we
are conﬁdent that the effects we observed are direct.
Our data point to an essential role of the helix a3 acidic
residue, E74 in 15.5K and E72 in Snu13p, in the recognition
of Snu13p and 15.5K by Rsa1p and NUFIP, respectively.
Interestingly, residue E74 is also conserved in proteins
NHP2 and SBP2 of the L7Ae family (Figure 1B), which
all interact with NUFIP (2). In contrast, this residue is not
conserved in the members of the L30 super-family which
do not belong to the L7Ae family (Figure 1B) (71).
Accordingly, co-expression and Y2H data failed to
detect an interaction between NUFIP and other
members of the L30 family that contain no counterparts
of residue E74 ((2) and data not shown). This suggests that
the presence of residue E74/E72 is a good predictor of the
interaction with NUFIP or Rsa1p.
In contrast to 15.5K, NHP2 and SBP2 do not bind to
the isolated PEP region of NUFIP (NUFIP223–260), sug-
gesting that regions other than PEP help the binding of
NUFIP to these proteins (Figure 1C and data not shown).
This stronger implication of amino acid sequences outside
of PEP may be linked to sequence variations within the
PEP recognition regions of these proteins. For instance,
amino acid sequence alignments show the replacement of
L71 in 15.5K (L69 in Snu13p) by a valine residue in NHP2
(V96 in human; Figure 1B). Furthermore, while the L71/V
mutation does not inhibit binding of 15.5K with full-
length NUFIP, this mutation prevents binding to
NUFIP223–260. Conversely, while NHP2 does not bind
NUFIP223–260, the V96/L substitution in NHP2 allows for-
mation of the interaction (Figure 1C). These observations
reinforce the idea that L71 in 15.5K and its counterpart L69
in Snu13p, which are components of the hydrophobic
pocket of these proteins, modulate their afﬁnity for the
isolated PEP region of Rsa1p and NUFIP, respectively.
However, consistent with a lack of major effect of L71/V
mutation in binding to full-length NUFIP, the similar
L69/A substitution in Snu13 only had a limited effect on
cell growth (Table 1). Therefore, for both Snu13p and
15.5K some residues other than PEP residues should con-
tribute somehow to the stability of the interaction with
Rsa1p/NUFIP, either by direct contact or by modulation
of the PEP conformation. Nevertheless, the requirement
of residues outside of PEP is quite lower for Snu13p/
15.5K as compared to NHP2 and SBP2, suggesting that
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residues L69/L71 which have no counterpart in these two
proteins may participate in the discrimination of Snu13p
and 15.5K from other L7Ae-like proteins.
Our 3D structure model reveals intricate electrostatic and
Van der Waals interactions at the Snu13p–Rsa1p
interface
By combining data from Y2H assays, site-directed muta-
genesis, co-expression assays, NMR analysis and
computer modeling, we built a comprehensive 3D struc-
ture model of the Snu13p–Rsa1p interaction. According
to this model, basic residues in Rsa1p (R246, R249 and
K250) and acidic residues in Snu13p (E72 and D73) form
a network of ionic interactions. However, we found that
only one of the Snu13p acidic residues (E72) and one of the
Rsa1p basic residues (R249) are indispensable for the inter-
action. Similarly, in Y2H assays, only the 15.5K E74
residue in protein 15.5K is essential for interaction of
15.5K with full-length NUFIP. Inspection of our model
brings some insight into this observation: the interaction
of E72 in Snu13p with the residue R249 in Rsa1p is likely
more stable than the interaction of D73 in Snu13p with
R246 and K250 residues in Rsa1p, probably because these
latter interactions are more solvent-exposed. We assume
that this explains why alanine substitutions of R246, and
also K250, in Y2H experiments do not disrupt the Snu13p–
Rsa1p interface. In contrast, according to our model, the
E72–R249 interaction is stabilized by surrounding hydro-
phobic residues shielding it from the solvent. Among these
hydrophobic residues, residue W245 in Rsa1p may play a
crucial role explaining why its mutation disrupts the inter-
action and has a strong effect on yeast growth. The
Snu13p residues F9, and L69 are also expected to protect
the E72–R249 ionic interaction against the solvent. In
addition, the side-chain of Y78 in Snu13p may be able to
ﬁx the guanidinium group of R249 in a conformation
favorable for the interaction with residue E72 in Snu13p.
Altogether, this can explain why residues Snu13p E72,
Rsa1p R249 and W245 are required for a stable
Snu13p–Rsa1p interaction and for optimal yeast cell
growth. The lower functional importance of the
D73(Snu13p)–R246(Rsa1p) interaction as compared to
the E72(Snu13p)–R249(Rsa1p) interaction is evidenced by
the similar growth rate defects of cells expressing the E72A
Snu13p variant and cells expressing the E72D73K74/AAA
Snu13p variant. Accordingly, the low functional import-
ance of the Rsa1p residue R246 is evidenced by the absence
of growth phenotype of yeast cells expressing the Rsa1p
R246A variant.
In our 3D structure model, the heterocyclic indol of
residue W253 is located in a hydrophobic pocket formed
by the aliphatic side-chains of Snu13p residues K7, F9, L65
and L69. We could reasonably assume that positioning of
residue W253 in the Snu13p pocket anchors the PEP region
of Rsa1p at the Snu13p surface. This can explain
why disruption of residue W253 abolishes the Snu13p–
Rsa1p238–261 interaction in Y2H assays. In addition, as
shown by these Y2H experiments, anchoring of residue
W253 seems to be particularly dependent from residues
K256 and I257 in Rsa1p. Importantly, the Rsa1p residue
W253 is quite well conserved in NUFIP (Y247), and the
Snu13p hydrophobic building blocks of its binding
pocket are conserved in the human 15.5K protein
(Supplementary Figure S2 and Figure 1B). This strongly
suggests that Van der Waals interactions similar to those
established by the yeast Rsa1p W253 residue are formed at
the 15.5K–NUFIP interface. Accordingly, mutation of
residue L71 in 15.5K had a negative effect on the
NUFIP223–260–15.5K interaction. Although in our
in vitro assays the L69/A mutation in Snu13p also had a
negative effect on the Snu13p–Rsa1p230–266 interaction,
residue L69 is not essential for yeast cell growth (Table
1). The four other hydrophobic amino acids in the
Snu13p pocket likely compensate for the L69/A mutation
in vivo. Therefore, we propose that the Snu13p–Rsa1p and
15.5K–NUFIP interactions are stabilized by interdepend-
ent electrostatic and Van der Waals interactions, requiring
the presence of four residues which are conserved from
yeast to human: E72 in Snu13p and its E74 homolog
in 15.5K, R249 in Rsa1p and its R243 counterpart in
NUFIP, W245 in Rsa1p and its W239 homolog in
NUFIP, and W253 in Rsa1p and its Y247 counterpart
in NUFIP (Figure 1B and Supplementary Figure S2).
In Y2H assays fragment Rsa1p238–261 gave a strong
positive signal with Snu13p. The K261A substitution had
no effect on the Snu13p afﬁnity (Table 2) suggesting that
at least the side-chain of this residue is not involved in the
interaction. The other missing residue in Rsa1p238–259,
residue N260, is not expected to have an orientation
allowing its interaction with Snu13p (Figure 8D and E).
However, the proposed model is based on conservation of
the helix fold of the peptide upon binding and we cannot
exclude some mild modulation of the helical structure of
the Rsa1p238–259 fragment by its surrounding sequences
within full-length Rsa1p or upon complex formation
with Snu13p. This might also explain why in our different
assays, the full-length Rsa1p seemed to have a slight dif-
ferent behavior toward Snu13p compared to shorter
Rsa1p fragments. Further experimental structure deter-
mination is needed to answer these questions.
One L7Ae residue in the archaeal counterpart of the
Snu13p EDK triplet develops an electrostatic interaction
with residue K289 in NOP5 and R135 in ﬁbrillarin
NUFIP and Rsa1p bind to the 15.5K and Snu13p proteins
on a face opposite to that needed for RNA binding
(Figure 3A). This is consistent with the possibility to
form a ternary complex containing the snoRNA, Snu13p
(or 15.5K) and Rsa1p (or NUFIP) plus the other assembly
factors. However, one important question is to know
whether the core proteins Nop56p, Nop58p and Nop1p
(or NOP56, NOP58 and Fibrillarin in human) recruited by
the combined action of Rsa1p and the R2TP complex can
form a stable mature snoRNP in the presence of Rsa1p or
whether Rsa1p has to leave the pre-snoRNP complex in
the ultimate steps of the assembly process. One way to get
insight into this question is to know whether the Snu13p
E72 and 15.5K E74 residues are available for interaction
with Rsa1p and NUFIP in mature box C/D snoRNPs, or
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Figure 10. L7Ae E75 residue, the archaeal counterpart of the D73 in Snu13p EDK motif makes electrostatic interactions with residue K289 in NOP5
and R135 in ﬁbrillarin. (A) Partial alignment of the amino acid sequence of L7Ae proteins from several archaea species with the corresponding amino
acid sequences of Homo sapiens 15.5K and S. cerevisiae Snu13p proteins reveals the conservation of two acidic residues at positions corresponding to
residues E72 and D73 in Snu13p. The alignment was established using CLUSTALW. Identical and similar amino acids are in dark gray and light gray
boxes, respectively. The conserved acidic residues corresponding to E72 and D73 and the more speciﬁc hydrophobic L69 of the W245 binding pocket in
Snu13p are in red. (B) The L7Ae residues L71, D74 and E75 in the S. solfataricus L7Ae protein corresponding to residues L69, E72 and D73 in Snu13p,
respectively, are located at the bottom of a narrow cavity in the active C/D box snRNP crystal structure. The PyMOL software was used to represent
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are involved in snoRNP internal protein–protein inter-
actions, or are buried inside the snoRNPs.
Up to now, no 3D structure of eukaryotic snoRNPs is
available to look for availability of residue E72/E74 in the
mature particle. However, several crystal structures of
archaeal box C/D sRNP have been recently established
(26,27), and archaeal and eukaryotes box C/D RNPs are
similar. Two types of substrate-bound archaeal structures
have been resolved by crystallography. The ﬁrst type
corresponds to an inactive half-mer sRNP, which
contains the three core proteins L7Ae, Fibrillarin, and
NOP5 (the archaeal homolog of NOP56/Nop56p and
NOP58/Nop58p) (27). The second type corresponds to a
catalytically active complete bipartite sRNP with two
copies of each core proteins on a same box C/D RNA
molecule (26). The main difference between these struc-
tures occurs on the so-called catalytic module, which is
composed of Fibrillarin and the Fibrillarin-binding
domain in NOP5. In the half-mer structure, this module
is located in an open conﬁguration, far away from the
RNA modiﬁcation site, and it must undergo a large rota-
tional movement to form the closed, active sRNP struc-
ture (27). A counterpart of the EDK motif is found in
helix a3 of archaeal L7Ae proteins (i.e. D74E75K76 in the
Sulfolobus solfataricus L7Ae protein) (Figure 10A). In the
open and inactive conﬁguration, the D74E75K76 motif of
S. solfataricus L7Ae protein is readily accessible. Thus,
if the eukaryotic motif has the same structure, it could
interact with NUFIP/Rsa1p. Remarkably however, for-
mation of the active structure and the necessary
movement of the catalytic module towards the
D74E75K76 motif of L7Ae creates an interaction between
this motif and both NOP5 and Fibrillarin, which appear
to maintain the catalytic module in the closed conﬁgur-
ation required for catalysis (Figure 10C). Indeed, in the
active closed structure, the L7Ae amino acids D74 and E75
of this motif and residue L71 corresponding to the L69
residue of Snu13p, are found at the interface between
L7Ae and NOP5, and Fibrillarin (Figure 10B). Whereas,
the L7Ae D74 residue appears to be free of interaction in
the active C/D box sRNP structure, its neighbor residue
E75 forms two stable electrostatic interactions with highly
conserved amino acids: one with the residue K289 of NOP5
(K310 in human) and the other one with residue R135 in
Fibrillarin (R218 in human) (Figure 10C–E). Therefore, it
clearly participates in the sRNP architecture. In addition,
residues D74 and L71 are located in a deep narrow cavity of
the snoRNP limiting their capacity of interaction with a
protein. Hence, if we assume similar interaction between
Snu13p, Nop56p or Nop58p and Fibrillarin as those
found for the archaeal proteins, we can conclude that
the Snu13p–Rsa1p interaction can occur in the inactive,
open snoRNP structure, but cannot take place in the
active and closed snoRNP structure. This feature likely
explains why NUFIP/Rsa1p speciﬁcally binds snoRNP
precursors, and further indicates that removal of
NUFIP/Rsa1p is a key event during snoRNP maturation.
It also suggests how the presence of Rsa1p could prevent
formation of the ﬁnal active snoRNP structures, which
may be important to prevent premature catalytic activity
of incompletely assembled snoRNPs.
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Figure 10. Continued
the complete S. solfataricus box C/D snRNP 3D structure (26) (PDB: 3PLA). L7Ae proteins are in pink, the NOP5 proteins in blue and Fibrillarin
(FIB) in orange. The RNA is in green. The cluster of L71, D74 and E75 residues is represented in red. An enlargement of the part of the 3D structure
containing these three residues is shown in the inset. (C) The carboxylate group of L7Ae residue E75 forms two ion pairs, one with NH3(+) group of
NOP5 residue K289 and another one with guanidium group of residue R135 in Fibrillarin. Moreover, residue L71 in L7Ae is located at the interface
between L7Ae, Fibrillarin and NOP5. Ribbon representation of the interactions between L7Ae, Fibrillarin and NOP5 in the crystal structure of a
S. solfataricus box C/D sRNP (26) (PDB: 3PLA). (D) Residue K289 in S. solfataricus NOP5, which interacts with the L7Ae E75 residue in the active
sRNP structure, is conserved in eukaryotic NOP56 and NOP58 proteins and in the U4 snRNP PRP31 protein. The alignment was performed as in
panel A. Identical and similar amino acids are in dark gray and light gray boxes, respectively. The conserved K residue corresponding to K289 in S.
solfataricus NOP5 is in red. (E) Residue R135 in S. solfataricus Fibrillarin, which interacts with the L7Ae E75 residue in the active sRNP structure, is
conserved in eukaryotic Fibrillarin proteins. The alignment was performed as in panel A. Identical and similar amino acids are in dark gray and light
gray boxes, respectively. The conserved R residue corresponding to R135 in S. solfataricus NOP5 is in red.
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